# Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

> **NCT07038213** · — · ENROLLING_BY_INVITATION · sponsor: **Astana Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Diabetes Mellitus
- Diabetic Nephropathy

## Interventions

- **GENETIC:** glycation genes
- **DIAGNOSTIC_TEST:** beta 2 microglobulin

## Key facts

- **NCT ID:** NCT07038213
- **Lead sponsor:** Astana Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-07-19
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07038213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07038213, "Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07038213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*